Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AVP | ridiculous renumeration | 13/01/09 | 0 | 968 | |||
|
|||||||
AVP | ridiculous renumeration | 13/01/09 | 0 | 903 | |||
|
|||||||
AVP | avp is now gcg | 30/07/07 | 0 | 1.3K | |||
|
|||||||
AVP | extra interest today | 24/07/07 | 1 | 1.8K | |||
|
|||||||
AVP | new direction for acuron | 25/04/07 | 3 | 2.6K | |||
|
|||||||
AVP | accumulation | 13/09/06 | 11 | 4.1K | |||
|
|||||||
AVP | funny business maybe | 21/08/06 | 1 | 1.1K | |||
|
|||||||
AVP | picking off | 27/06/06 | 0 | 441 | |||
|
See All Discussions